Monogram Biosciences, Inc. (Nasdaq: MGRM) announced today that William D. Young, Chairman of the Board and Chief Executive Officer, is scheduled to present a corporate overview at the 8th Annual JMP Securities Research Conference on Monday, May 18 at 11:30 a.m. Eastern Time (8:30 a.m. Pacific Time) at the Ritz-Carlton Hotel in San Francisco, California.

To access the live audio broadcast or the subsequent archived recording, log on to http://www.monogrambio.com and go to the investor relations section (�Investors/Media� tab) and click on the �Events & Webcasts� link provided on the sidebar menu on the page.

About Monogram Biosciences, Inc.

Monogram is advancing individualized medicine by discovering, developing and marketing innovative products to guide and improve treatment of serious infectious diseases and cancer. The Company's products are designed to help doctors optimize treatment regimens for their patients that lead to better outcomes and reduced costs. The Company's technology is also being used by numerous biopharmaceutical companies to develop new and improved antiviral therapeutics and vaccines as well as targeted cancer therapeutics. More information about the Company and its technology can be found on its web site at www.monogrambio.com.

Monogram Technologies (NASDAQ:MGRM)
Gráfica de Acción Histórica
De Oct 2024 a Nov 2024 Haga Click aquí para más Gráficas Monogram Technologies.
Monogram Technologies (NASDAQ:MGRM)
Gráfica de Acción Histórica
De Nov 2023 a Nov 2024 Haga Click aquí para más Gráficas Monogram Technologies.